Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Chemical Communications (Cambridge, England)|April 13, 2016
Can computed crystal energy landscapes help understand pharmaceutical solids?Sarah L Price, Doris E Braun, Susan M Reutzel-EdensMolecular Pharmaceutics|June 16, 2015
Navigating the Waters of Unconventional Crystalline HydratesDoris E Braun, Lien H Koztecki, Jennifer A McMahon, et al.Drug Discovery Today|February 7, 2016
The potential of computed crystal energy landscapes to aid solid-form developmentSarah L Price, Susan M Reutzel-EdensCrystal Growth & Design|October 12, 2017
Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?Doris E Braun, Sreenivas R Lingireddy, Mark D Beidelschies, et al.The Journal of Chemical Physics|December 31, 2020
Diabat method for polymorph free energies: Extension to molecular crystalsKartik Kamat, Rui Guo, Susan M Reutzel-Edens, et al.Current Opinion in Drug Discovery & Development|November 23, 2006
Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advancesSusan M Reutzel-EdensFaraday Discussions|July 25, 2018
Crystal structure prediction is changing from basic science to applied technologyJonas Nyman, Susan M Reutzel-EdensIucrj|November 19, 2020
Crystal forms in pharmaceutical applications: olanzapine, a gift to crystal chemistry that keeps on givingSusan M Reutzel-Edens, Rajni M BhardwajChemical Communications (Cambridge, England)|April 9, 2011
Which, if any, hydrates will crystallise? Predicting hydrate formation of two dihydroxybenzoic acidsDoris E Braun, Panagiotis G Karamertzanis, Sarah L PriceJournal of Pharmaceutical Sciences|October 10, 2017
Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral BioavailabilityAnn Newman, Susan M Reutzel-Edens, George ZografiPageof 14